CLINICAL_TRIALS
trial_result
· 2013-11-14
Clinical Trial Update: Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) [Phase 3]
Summary
A Phase 3 trial evaluating the AeriSeal System for reducing hyperinflation in emphysema was terminated before completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema | Phase 3 | Status: TERMINATED